Sobi reports increase in share capital following employee incentive plan

The newly issued shares support the All Employee Programme, which provides equity-based commitments to permanent staff members. By utilizing the conversion clause within the company's articles of association, Sobi integrated these class C holdings directly into its common share pool. Each share carries one vote, bringing the total voting power in line with the updated share count.

Following these adjustments, Sobi currently maintains a treasury position of 9,631,955 common shares. The biopharmaceutical firm, which focuses on treatments for rare diseases, operates across major global markets with approximately 2,000 employees. The company’s stock remains listed on Nasdaq Stockholm under the ticker symbol SOBI.